The cornea is exposed daily to solar ultraviolet (UV) radiation, which is known to induce damage to DNA as well as initiate oxidative stress.^[@i1552-5783-57-4-2319-b01]^ In a natural environment, UV-A with the wavelengths of 320 to 400 nm constitutes approximately 95% of the UV radiation that reaches the earth\'s surface. Different from UV-B (280--320 nm), which can be absorbed by the bases in DNA directly, UV-A wavelengths are not well absorbed by native DNA and induce reactive oxygen species (ROS) causing oxidative damage.^[@i1552-5783-57-4-2319-b01]^ Based on the observations of UV-A intensity of different areas around the world, it is estimated that 10 J/cm^[@i1552-5783-57-4-2319-b02]^ of UV-A equates to approximately 2 hours of exposure of sunlight at noon time during the summer.^[@i1552-5783-57-4-2319-b02]^ Ultraviolet A penetrates all corneal layers including endothelium.^[@i1552-5783-57-4-2319-b03]^ Human corneal endothelial cells (CEnCs) are arrested in the post mitotic state and have limited proliferative and repair capacity in vivo. Therefore, CEnCs damaged by aging or disease do not have the capacity to regenerate. The adverse effect of UV-A on CEnCs remains unclear. Limited safety studies of corneal collagen crosslinking using UV-A showed that high doses of UV-A irradiation caused rabbit CEnC cell apoptosis and necrosis.^[@i1552-5783-57-4-2319-b04],[@i1552-5783-57-4-2319-b05]^ Given that CEnCs are particularly susceptible to oxidative damage due to their high aerobic metabolic activity and lifelong exposure to sunlight^[@i1552-5783-57-4-2319-b06]^ studying the effect of UV-A, the natural physical oxidative stressor on CEnCs would provide the basis for the role of UV-A in corneal endothelial degeneration.

Fuchs endothelial corneal dystrophy (FECD) is a leading cause of endogenous corneal endothelial degeneration. Previous studies showed that oxidant--antioxidant imbalance plays a major role in the chronic degenerative process of corneal endothelium (CE) and apoptosis seen in FECD.^[@i1552-5783-57-4-2319-b07]^ Corneal endotheliums exhibited an increased level of oxidative DNA damage and apoptosis in FECD as compared with that seen in normal cells.^[@i1552-5783-57-4-2319-b07],[@i1552-5783-57-4-2319-b08]^ Moreover, decreased levels of different antioxidants, such as glutathione S-transferase (GST), aldehyde dehydrogenase 3A1 (ALDH3A1), peroxiredoxins (Prdx), superoxide dismutase 2 (SOD2), thioredoxin reductase 1 (TXNRD1), and heme oxygenase 1(HO-1) were detected in FECD.^[@i1552-5783-57-4-2319-b07],[@i1552-5783-57-4-2319-b09][@i1552-5783-57-4-2319-b10]--[@i1552-5783-57-4-2319-b11]^ Proximal promoter sequence analysis of downregulated antioxidants revealed a consensus sequence called antioxidant responsive element (ARE). Importantly, nuclear factor erythroid 2--related factor 2 (Nrf2), which is a master regulator of ARE**-**mediated antioxidants, showed decreased protein levels in FECD as well.^[@i1552-5783-57-4-2319-b07]^

Transcription factors Nrf2 and p53 play key roles in the stress response. Under oxidative stress conditions, Nrf2 is known to cause a coordinated upregulation of antioxidant defense.^[@i1552-5783-57-4-2319-b12][@i1552-5783-57-4-2319-b13][@i1552-5783-57-4-2319-b14]--[@i1552-5783-57-4-2319-b15]^ p53 may coordinate many biological processes including cell-cycle arrest, apoptosis, senescence, and DNA repair.^[@i1552-5783-57-4-2319-b16]^ p53 phosphoprotein acts as a guardian of the cell by either repairing DNA damage or by inducing cell apoptosis.^[@i1552-5783-57-4-2319-b17][@i1552-5783-57-4-2319-b18]--[@i1552-5783-57-4-2319-b19]^ When ROS-induced damage is irreparable, p53 promotes cell apoptosis.^[@i1552-5783-57-4-2319-b20],[@i1552-5783-57-4-2319-b21]^ At present, the interaction of Nrf2 and p53 under UV-A--induced oxidative damage remains unclear.^[@i1552-5783-57-4-2319-b22][@i1552-5783-57-4-2319-b23][@i1552-5783-57-4-2319-b24][@i1552-5783-57-4-2319-b25][@i1552-5783-57-4-2319-b26][@i1552-5783-57-4-2319-b27][@i1552-5783-57-4-2319-b28][@i1552-5783-57-4-2319-b29][@i1552-5783-57-4-2319-b30]--[@i1552-5783-57-4-2319-b31]^

Our previous studies showed the deficiency of DJ-1, Nrf2, and Nrf2-regulated antioxidants, such as HO-1 in FECD.^[@i1552-5783-57-4-2319-b07],[@i1552-5783-57-4-2319-b32]^ Moreover, elevated levels of p53 along with heightened oxidative damage and apoptosis were found in FECD.^[@i1552-5783-57-4-2319-b08]^ Importantly, a downregulation of DJ-1, the main regulator of Nrf2, leads to CEnC susceptibility to UV-A--induced damage.^[@i1552-5783-57-4-2319-b33]^ Nevertheless, the effect of UV-A, the main source of physiological oxidative stress, has not yet been explored in relation to Nrf2 and p53 pathways in human CEnCs. Because these pathways are affected by FECD, the study herein has specific relevance to FECD pathogenesis. We aimed to determine the responses of Nrf2 and p53 under UV-A--induced oxidative stress in CEnCs. Using the fluences similar to those the CE are exposed to in daily life, we evaluated ROS production, Nrf2-regulated antioxidant defense, p53, and cell apoptosis in human CEnCs exposed to varying UV-A fluences along with cells allowed to recover following UV-A treatment. Our findings provided not only the cellular response of CEnCs to UV-A--induced oxidative stress, but also an in vitro model for studying CEnC pathogenesis under natural environmental conditions.

Materials and Methods {#s2}
=====================

Human Corneal Endothelial Cell Culture {#s2a}
--------------------------------------

Normal human corneal endothelial cells (HCEnCi), immortalized by infection with an amphotropic recombinant retrovirus containing human papilloma virus type 16 genes E6 and E7, were a generous gift from May Griffith, PhD, (Ottawa Hospital Research Institute, Ottawa, Ontario, Canada).^[@i1552-5783-57-4-2319-b34]^ Cells were grown in tissue culture flasks or petri dishes in Chen\'s medium^[@i1552-5783-57-4-2319-b35]^ at 37°C with 5% CO~2~.

UV-A Irradiation {#s2b}
----------------

A fluorescent UV-A broadband lamp (The Southern New England Ultraviolet Co., Branford, CT, USA) was used for irradiation. Twenty-four hours prior to the UV-A treatment, HCEnCi growth medium was replaced with Opti-MEM I reduced serum medium (Invitrogen, Carlsbad, CA, USA). Ultraviolet A treatment was performed in a biosafety laminar hood with the fluence of 2.5, 5, 10, or 25 J/cm^2^. Immortalized human CEnCs were washed with 37°C Hank\'s balanced salt solution (HBSS) and then the cells were placed under UV-A light without a petri dish lid followed by recovery period in Opti-MEM I reduced serum medium at 37°C with 5% CO~2~ for 0, 3, 6, 18, or 24 hours. Controls were treated identically, except they were not exposed to UV-A.

ROS Production Assay {#s2c}
--------------------

Immediately post UV-A treatment, the cells were washed with warm HBSS (Invitrogen) and then loaded with 25 μM 5-(and −6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate (carboxy-H~2~DCFDA; Invitrogen) for 30 minutes at 37°C. Cells were harvested with a scraper, washed with warm HBSS, and centrifuged at 500*g* for 5 minutes. Cells were then suspended in 110 μL of warm HBSS; 100 μL of the cell suspension was transferred to a flat-bottom black 96-well plate for the carboxy-H~2~DCFDA fluorescence assay and 10 μL was used for the cell viability assay. The cell number and viability immediately after UV-A irradiation were measured by Trypan blue staining using an automatic cell counter (Countess; Life Technologies, Carlsbad, CA, USA). The carboxy-H~2~DCFDA fluorescence (485/520 nm) was analyzed using a fluorescence microplate reader (BioTek-Synergy 2; BioTek Instruments, Inc., Winooski, VT, USA). Relative fluorescence units were normalized to the cell number.

Cytotoxicity Assay {#s2d}
------------------

Cytotoxicity was measured by evaluating lactate dehydrogenase (LDH) release according to the manufacturer\'s instructions (CytoTox 96 Non-radioactive Cytotoxicity Assay; Promega, Madison, WI, USA). Briefly, at 3, 6, and 24 hours post UV-A irradiation, 50 μL of cell culture medium was transferred to a 96-well plate after centrifugation, and 50 μL of substrate was added to each well and mixed. The mixture was incubated for 30 minutes at room temperature in the dark, followed by the addition of 50 μL of stop solution to each well. The plate was read at 490 nm using an absorbance microplate reader (SpectraMax 34; Molecular Devices, Silicon Valley, CA, USA). One hundred percent cell death was determined by rupturing all cells using cell lysis solution provided in the kit. The LDH release levels were normalized to the control of 100% cell death.

Real-Time RT-PCR {#s2e}
----------------

Total RNA from HCEnCi was extracted using RNeasy Mini Kit (Qiagen, Valencia, CA, USA). Complementary cDNA was prepared by reverse transcription with a commercial kit (Promega) in a MyCycler Thermal cycler (Bio-Rad, Hercules, CA, USA), according to the manufacturer\'s protocol. *Taq*Man primers and probes for Nrf2, HO-1and NQO1 genes, as well as for the endogenous control β~2~-microglobulin (β~2~-MG), were obtained from Applied Biosystems (Foster City, CA, USA). Real-time RT PCR reactions were set up with the Probe Fast master mix (Kapa Biosystems, Woburn, MA, USA) and performed in Mastercycler Realplex2 (Eppendorf, Hamburg, Germany). Each gene was detected in duplicate and repeated three times. For data analysis, the comparative threshold cycle (CT) method was performed using β~2~-MG as the calibrator.

Subcellular Fractionation {#s2f}
-------------------------

Immortalized human CEnCi were pretreated with 5 mM of N-acetyl-L-cysteine (NAC; Sigma-Aldrich Corp., St. Louis, MO, USA) 1 hour prior to 5 J/cm^2^ UV-A irradiation. At 6 hours post UV-A, cytosolic and nuclear extracts were sequentially isolated using a nuclear/cytosol fractionation kit (BioVision, Milpitas, CA, USA) according to the manufacturer\'s instructions. Untreated HCEnCi served as controls.

Western Blot Analysis {#s2g}
---------------------

Whole-cell extracts from HCEnCi were lysed with ×1 RIPA buffer (Cell Signaling Technology, Danvers, MA, USA) supplemented with a protease and phosphatase inhibitor cocktail (Pierce, Waltham, MA, USA), followed by brief sonication (Sonifier 250; Branson, Danbury, CT, USA). Protein concentrations were determined by BCA protein assay (Pierce). Proteins were separated in 10% or 12% Bis-Tris NuPAGE gels (Invitrogen) and electroblotted to polyvinylidene difluoride (PVDF) membranes (Millipore, Billerica, MA, USA). Membranes were blocked with 5% dry non-fat milk in TBS for 1 hour and then incubated overnight at 4°C with the following primary antibodies: mouse monoclonal anti-Nrf2 (1:400; R&D Systems); mouse monoclonal anti-phospho-p53 (Ser15; 1:1000; Cell Signaling Technology); rabbit polyclonal anti-p53 (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA, USA) rabbit monoclonal anti-cleaved Caspase 3 (1:1500; Cell Signaling Technology); rabbit polyclonal anti-GAPDH (1:4000; Santa Cruz Biotechnology) and mouse anti-β-actin (1:4000; Sigma-Aldrich Corp.). Blots were washed with TTBS (50 nM Tris, pH 7.5, 0.9% NaCl~2~ and 0.1% Tween-20) and exposed for 1 hour to horseradish peroxidase (HRP)-conjugated secondary antibody: goat anti-mouse IgG, 1:1000 for Nrf2 (R&D Systems), 1:2000 for phospho-p53 (Ser 15), 1:4000 for cleaved caspase3 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) blots. After washing in TTBS, antibody binding was detected with a chemiluminescent substrate (Thermo Scientific, Waltham, MA, USA). Densitometry was analyzed with ImageJ software (<http://imagej.nih.gov/ij/>; provided in the public domain by the National Institutes of Health, Bethesda, MD, USA).

Immunocytochemistry {#s2h}
-------------------

Prior to UV-A irradiation, HCEnCi were pretreated with sulforaphane (1-isothiocyanato-\[4R\]-\[methylsulfinyl\]-butane, SFN, 2 μM) over night or with *N*-acetyl-L-cysteine (NAC, 5 mM) for 1 hour. Immunocytochemistry was performed at 6 hours post 5 J/cm^2^ UV-A. Nrf2 subcellular localization was detected using anti-Nrf2 antibody (H-300, 1:200; Santa Cruz Biotechnology). Untreated HCEnCi served as controls. Images were viewed by confocal microscopy (Leica DM6000S; Leica Microsystems, Mannheim, Germany).

Apoptosis Assay {#s2i}
---------------

Activated caspase3 was detected by Western blot analysis with anti-cleaved caspase3 (Asp175; 5A1) rabbit mAb (Cell Signaling Technology) and by the EnzChek Caspase3 Assay Kit \#2 (Invitrogen; Molecular Probes) following the manufacturer\'s instructions. Briefly, after treatment, the cells were washed in cold PBS and lysed. Caspase 3 activity in the cell lysates was determined by the detection of fluorescence generated by the cleavage of the substrate Z-DEVD-rhodamine 110 using a fluorescence microplate reader (BioTek-Synergy 2) with excitation/emission at 496/520 nm. Procaspase3 was detected by western blot analysis with an anti-casapse 3 (8G10) rabbit mAb (Cell Signaling Technology).

Statistical Analysis {#s2j}
--------------------

Statistical analysis was carried out using the Bonferroni posttest two-way ANOVA. *P* less than 0.05 was considered to be statistically different. Data were expressed as the mean ± SEM.

Results {#s3}
=======

UV-A Irradiation Causes Cytotoxicity {#s3a}
------------------------------------

Post UV-A irradiation, we examined the HCEnCi morphology by imaging and evaluated the cell cytotoxicity by measuring the LDH levels. Phase-contrast microscopy showed that the cell confluence and morphology immediately after UV-A exposure were similar to controls. However, a small number of bright and rounded up cells that loosely adhered to the cell layer were observed 6 hours after 25 J/cm^2^ UV-A treatment, indicating cell death. This change was also observed 24 hours after 5, 10, and 25 J/cm^2^ UV-A treatments ([Fig. 1](#i1552-5783-57-4-2319-f01){ref-type="fig"}A). Concurrently, the LDH based cytotoxicity assay showed that UV-A exposure caused elevated levels of LDH release with increased UV-A fluences, indicating cell death from 13% to 42% at 24 hours post 2.5, 5, 10, and 25 J/cm^2^ UV-A treatments ([Fig. 1](#i1552-5783-57-4-2319-f01){ref-type="fig"}B). Two-way ANOVA indicated that after 24 hours recovery, 5, 10, and 25 J/cm^2^ UV-A treatments produced significant changes in cell death compared with no UV-A treatment ([Fig. 1](#i1552-5783-57-4-2319-f01){ref-type="fig"}B, *P* \< 0.05).

![Cell cytotoxicity and ROS production in UV-A irradiated HCEnCi. (**A**) Representative phase-contrast microcopy images of HCEnCi at 0, 6, and 24 hours post UV-A irradiation with the fluences of 2.5, 5, 10, and 25 J/cm^2^. Immortalized human CEnCi not exposed to UV-A irradiation were used as a baseline control. *Bar* represents 100 μm. (**B**) Lactate dehydrogenase--based cytotoxicity assay showed elevated LDH release with increased UV-A fluences, indicating cell death increases with higher fluences of UV-A irradiation. (**C**) DCFDA assay of HCEnCi post various UV-A irradiation. Results showed that ROS levels increased with increasing UV-A fluences. \**P* \< 0.05.](i1552-5783-57-4-2319-f01){#i1552-5783-57-4-2319-f01}

UV-A Irradiation Induces ROS Production {#s3b}
---------------------------------------

It has been shown that UV-A stimulates the production of ROS in many cell types. Consequently, we determined whether ROS were formed using our UV-A treatment regimen. We measured the ROS production levels and cell viability immediately after UV-A irradiation. As [Figure 1](#i1552-5783-57-4-2319-f01){ref-type="fig"}C shows, exposure of HCEnCi to 5, 10, and 25 J/cm^2^ of UV-A radiation generated elevated levels of ROS production compared with those produced in the untreated controls (*P* \< 0.05). The same UV-A treatments did not alter cell viability in those samples ([Supplementary Fig. S1](#i1552-5783-57-4-2319-s01){ref-type="supplementary-material"}, *P* \> 0.05), suggesting that ROS were produced by viable HCEnCi with a fluence of 5, 10, or 25 J/cm^2^ UV-A.

UV-A Irradiation Activates Nrf2-Regulated Antioxidant Defense {#s3c}
-------------------------------------------------------------

To investigate whether Nrf2-regulated antioxidant defense plays a critical role in protection against UV-A irradiation in HCEnCi, we analyzed the transcriptional and translational levels of Nrf2 and its regulated antioxidants post UV-A exposure. Real-time RT-PCR showed the mRNA levels of Nrf2 increased greater than 2.0-fold at 3 hours after 2.5 and 5 J/cm^2^ UV-A and at 6 hours after 5 J/cm^2^ UV-A irradiation compared with controls ([Fig. 2](#i1552-5783-57-4-2319-f02){ref-type="fig"}A, *P* \< 0.05). The mRNA levels of the Nrf2-regulated gene HO-1 showed a significant 2.3-fold increase with the 2.5 J/cm^2^ UV-A and peaked with a 3.2-fold increase with 5 J/cm^2^ UV-A irradiated cells at 3-hours recovery ([Fig. 2](#i1552-5783-57-4-2319-f02){ref-type="fig"}B, *P* \< 0.05), which correlated with the Nrf2 mRNA increases. In addition, NQO-1, another Nrf2-regulated gene showed a 1.7-fold increase in mRNA levels 3 hours after 2.5 J/cm^2^ UV-A exposure ([Fig. 2](#i1552-5783-57-4-2319-f02){ref-type="fig"}C, *P* \< 0.05). Interestingly, the fluence and recovery time-dependent increases of Nrf2 and HO-1were not observed after the higher UV-A fluence exposures ([Figs. 2](#i1552-5783-57-4-2319-f02){ref-type="fig"}A, [2](#i1552-5783-57-4-2319-f02){ref-type="fig"}B). Western blot analysis demonstrated that elevated protein levels of Nrf2 and HO-1occured in 2.5 and 5 J/cm^2^ UV-A--treated HCEnCi in a fluence and recovery time-dependent manner ([Fig. 2](#i1552-5783-57-4-2319-f02){ref-type="fig"}D).

![The effect of UV-A irradiation on Nrf2 and its target genes. The mRNA levels of Nrf2 (**A**), HO-1 (**B**), and NQO 1 (**C**) were analyzed with real time RT-PCR post UV-A irradiation at different recovery time points. Results were expressed as fold changes and normalized to β2-microglobulin. The protein levels of Nrf2, HO-1 and NQO-1 were analyzed by Western blotting (**D**). Ultraviolet A upregulates Nrf2, HO-1, and NQO1 with 2.5 and 5 J/cm^2^ UV-A treatment. \**P* \< 0.05.](i1552-5783-57-4-2319-f02){#i1552-5783-57-4-2319-f02}

UV-A Irradiation Promotes Nrf2 Nuclear Translocation {#s3d}
----------------------------------------------------

Knowing that UV-A treatments activate Nrf2 and its target genes, we postulated that UV-A enhances Nrf2 nuclear translocation, which is essential for the activation of Nrf2-regulated antioxidant defense. To test this hypothesis, we examined nuclear Nrf2 levels after 5 J/cm^2^ UV-A treatment combined with and without NAC or SFN pretreatments, respectively, at 6 hours post irradiation. NAC is an aminothiol and considered an important antioxidant. SFN is a well-studied chemoprotective compound inducing Nrf2-regulated antioxidant responses. The confocal images ([Fig. 3](#i1552-5783-57-4-2319-f03){ref-type="fig"}A) showed diffuse cytosolic and nuclear staining of Nrf2 in cells without UV-A treatment ([Fig. 3](#i1552-5783-57-4-2319-f03){ref-type="fig"}A, columns 1--3). However, increased Nrf2 staining was observed in nuclei 6 hours post UV-A treatment ([Fig. 3](#i1552-5783-57-4-2319-f03){ref-type="fig"}A, column 4). Similarly, intense Nrf2 nuclear staining was seen in NAC pretreatment at 6 hours post UV-A ([Fig. 3](#i1552-5783-57-4-2319-f03){ref-type="fig"}A, column 5). With SFN pretreatment, increased Nrf2 nuclear staining was observed in UV-A irradiated cells ([Fig. 3](#i1552-5783-57-4-2319-f03){ref-type="fig"}A, column 6) as compared with that of UV-A treatment alone, suggesting that SFN enhances Nrf2 movement from the cytoplasm to the nucleus under UV-A oxidative stress. Meanwhile, Western blot analysis of subcellular Nrf2 showed that there was an increase in nuclear Nrf2 levels in UV-A--treated cells as compared with no UV-A treatment ([Fig. 3](#i1552-5783-57-4-2319-f03){ref-type="fig"}B), suggesting the translocation of Nrf2 from the cytoplasm to nuclei in response to UV-A irradiation. With NAC pretreatments, both immunostaining and Western blotting showed similar nuclear Nrf2 levels as seen in UV-A irradiated cells ([Fig. 3](#i1552-5783-57-4-2319-f03){ref-type="fig"}A, columns 4, 5; [Fig. 3](#i1552-5783-57-4-2319-f03){ref-type="fig"}B), indicating that NAC along with UV-A irradiation did not significantly change Nrf2 nuclear translocation compared with UV-A treatment alone.

![Nuclear localization of Nrf2 in UV-A irradiated cells. (**A**) Representative confocal images of Nrf2 localization in cells with no treatment (*column 1*), NAC-treated (*column 2*), SFN-treated (*column 3*), UV-A irradiated (*column 4*), UV-A irradiated with NAC-pretreatment (*column 5*), and UV-A irradiated with SFN-pretreatment (*column 6*). Nrf2 (*green*) was initially diffused in cytoplasm and nuclei. After treatment with UV-A and SFN, Nrf2 accumulated primarily in the nuclei. DAPI was used for nuclei staining (*blue*). *Bar* represents 25 μm. (**B**) Western blot analysis of cytosolic and nuclear Nrf2 in UV-A or UV-A-- and NAC-treated cells. GAPDH and histone H3 were used for normalization of cytosolic and nuclear protein loading, respectively. Cells were irradiated with 5 J/cm^2^ UV-A and collected at 6 hours post UV-A.](i1552-5783-57-4-2319-f03){#i1552-5783-57-4-2319-f03}

UV-A Irradiation Activates p53 and Induces Accumulation of Nuclear Phospho-p53 {#s3e}
------------------------------------------------------------------------------

To determine the role of p53 in HCEnCi under UV-A--induced oxidative stress, the protein levels of p53 and phosphorylated p53 (phospho-p53) at serine 15 were analyzed. [Figures 4](#i1552-5783-57-4-2319-f04){ref-type="fig"}A and [4](#i1552-5783-57-4-2319-f04){ref-type="fig"}B indicate that phospho-p53 showed a recovery time-dependent accumulation at all of the UV-A fluences. Fluences of 5, 10, and 25 J/cm^2^ UV-A yielded a significant 1.8- to 2.8-fold increase in phospho-p53 (*P* \< 0.05, [Fig. 4](#i1552-5783-57-4-2319-f04){ref-type="fig"}A) compared with no UV-A treatment at 24 hours post exposure, indicating that these fluences functionally activate p53 by a phosphorylation modification at serine 15 ([Fig. 4](#i1552-5783-57-4-2319-f04){ref-type="fig"}B). It is worthy to point out that 5 J/cm^2^ UV-A showed the most robust accumulation of phospho-p53 as compared with the other fluences at 24 hours post UV-A treatment. Fractionation of cytosolic and nuclear protein showed that phospho-p53 is exclusively expressed in nuclei after 5 J/cm^2^ UV-A treatment at 6-hours recovery. Moreover, UV-A irradiation enhanced phospho-p53 accumulation in the nuclei. Meanwhile, total p53 levels showed a decrease in the cytosol of UV-A irradiated cells, suggesting UV-A treatment may facilitate the movement of total p53 from the cytosol to the nuclei ([Fig. 4](#i1552-5783-57-4-2319-f04){ref-type="fig"}C). In addition, elevated phospho-p53 levels were detected in UV-A irradiated cells with NAC pretreatment ([Fig. 4](#i1552-5783-57-4-2319-f04){ref-type="fig"}C).

![Ultraviolet-A irradiation activates p53 in HCEnCi. **(A)** Representative Western blot of phospho-p53 and total p53 protein levels and (**B**) densitometric analysis of phospho-p53 with normalization to β-actin. (**C**) Western blot analysis of cytosolic and nuclear phospho-p53 and total p53 in 5 J/cm^2^ UV-A-- or NAC-pretreated cells followed by 5 J/cm^2^ UV-A at 6 hours recovery. Results showed that phospho-p53 increases at 24 hours post 5, 10, and 25 J/cm^2^ as compared with no UV-A treatment, and UV-A causes accumulation of nuclear phospho-p53.](i1552-5783-57-4-2319-f04){#i1552-5783-57-4-2319-f04}

UV-A Irradiation Activates Cell Apoptosis {#s3f}
-----------------------------------------

Caspase3 plays a central role in the execution-phase of cell apoptosis. To assess the effect of UV-A on HCEnCi apoptosis, we examined the protein levels of activated caspase3 in UV-A irradiated cells. Western blot analysis ([Fig. 5](#i1552-5783-57-4-2319-f05){ref-type="fig"}A) showed that cleaved caspase3 levels were elevated by the increased UV-A fluences and the recovery times that followed despite similar levels of pro-caspase3. [Figure 5](#i1552-5783-57-4-2319-f05){ref-type="fig"}B shows the results from a rhodamine 110 fluorescence-based caspase3 activation assay. At 24 hours post treatment with 5, 10, and 25 J/cm^2^ UV-A, a 2.6- to 6.0-fold increase was produced in activated caspase3 as compared with no UV-A treatment (*P* \< 0.05, [Fig. 5](#i1552-5783-57-4-2319-f05){ref-type="fig"}B).

![UV-A irradiation activates caspase3 in HCEnCi. (**A**) Western blot analysis of cleaved caspase3 and pro-caspase3 in HCEnCi cells. (**B**) Z-DEVD-rhodamine 110 fluorescence-based casapase3 activity assay. Results showed that activated caspase3 increases at 24 hours post 5, 10, and 25 J/cm^2^ as compared with no UV-A treatment.](i1552-5783-57-4-2319-f05){#i1552-5783-57-4-2319-f05}

Discussion {#s4}
==========

There is growing evidence indicating that CE degeneration is associated with oxidative stress in aged and diseased corneal endothelium.^[@i1552-5783-57-4-2319-b07][@i1552-5783-57-4-2319-b08]--[@i1552-5783-57-4-2319-b09],[@i1552-5783-57-4-2319-b32],[@i1552-5783-57-4-2319-b33],[@i1552-5783-57-4-2319-b36],[@i1552-5783-57-4-2319-b37]^ Our previous studies on FECD specimens and FECD CEnCs showed that Nrf2 and p53 play critical roles in complex mechanisms regulating oxidative-stress--induced apoptosis in FECD.^[@i1552-5783-57-4-2319-b07],[@i1552-5783-57-4-2319-b08],[@i1552-5783-57-4-2319-b32]^ Ultraviolet A is the most abundant source of solar radiation and it induces ROS production. To investigate the cellular response of CEnC to UV-A, we examined the effect of UV-A on Nrf2-regulated antioxidant defense, p53 activation, and cell apoptosis. Using UV-A fluences similar to those the CE are exposed to in daily life, we found that UV-A irradiation causes fluence-dependent ROS production and cytotoxicity. Ultraviolet A facilitates Nrf2 nuclear translocation and induces Nrf2-regulated antioxidant defense. Meanwhile, UV-A activates p53 and caspase3. Collectively, these findings suggested that UV-A activates Nrf2-regulated antioxidant defense and induces apoptosis.

Nrf2 plays a critical role in antioxidant defense under oxidative stress conditions.^[@i1552-5783-57-4-2319-b12][@i1552-5783-57-4-2319-b13][@i1552-5783-57-4-2319-b14]--[@i1552-5783-57-4-2319-b15]^ It has been demonstrated that, in normal physiological condition, Nrf2 localizes in the cytoplasm before being ubiquitinated and degraded by Kelch-like ECH-associated protein (Keap1) and Cullin3. However, under oxidative stress conditions, the ROS and electrophiles bind to sulfhydryl residues of Keap1. As a result, the released Nrf2 translocates to the nucleus, where it binds to ARE in the promoter region of some anti-oxidative genes and transcriptionally facilitates expression of antioxidants, including HO-1, NAD(P)H: quinone oxidoreductase 1 (NQO1).^[@i1552-5783-57-4-2319-b12][@i1552-5783-57-4-2319-b13][@i1552-5783-57-4-2319-b14]--[@i1552-5783-57-4-2319-b15]^ In this study, we detected increased levels of Nrf2 and its target genes HO-1 and NQO-1 with the UV-A fluences of 2.5 and 5 J/cm^2^. Moreover, we observed increased levels of nuclear Nrf2 in UV-A treated HCEnCi, indicating that UV-A facilitate Nrf2 nuclear translocation. These results suggest that UV-A activates Nrf2 and its regulated antioxidant defense. This finding is supported by previous reports that UV-A irradiation with a fluence of 5 to 37.2 J/cm^2^ leads to the induction of Nrf2-regulated antioxidant HO-1 in dermal fibroblasts^[@i1552-5783-57-4-2319-b22][@i1552-5783-57-4-2319-b23]--[@i1552-5783-57-4-2319-b24]^ and keratinocytes,^[@i1552-5783-57-4-2319-b25],[@i1552-5783-57-4-2319-b38]^ retinal pigment epithelial cells^[@i1552-5783-57-4-2319-b39]^ as well as mouse embryonic fibroblasts.^[@i1552-5783-57-4-2319-b40]^ Studies on skin fibroblasts demonstrated that UV-A irradiation resulted in an increase in Nrf2 and its regulated gene HO-1at both the mRNA^[@i1552-5783-57-4-2319-b22]^ and protein^[@i1552-5783-57-4-2319-b24]^ level. Downregulation of Nrf2 inhibits mRNA expression of ARE dependent genes,^[@i1552-5783-57-4-2319-b22],[@i1552-5783-57-4-2319-b24]^ such as HO-1, but not other UV-A regulated genes, such as Cox2 and IL-6,^[@i1552-5783-57-4-2319-b22]^ indicating that UV-A selectively induces Nrf2-dependent antioxidant defense. However, analysis of keratinocytes from mice transgenic for ARE activation showed that 5 to 20 J/cm^2^ UV-A did not activate Nrf2 regulated antioxidants in vivo and in vitro although UV-A irradiation strongly increased intracellular ROS levels.^[@i1552-5783-57-4-2319-b26]^ These findings suggested that the induction of Nrf2-regulated antioxidant defense may be cell-type dependent.

P53 plays dual roles under oxidative stress, either by repairing DNA damage or by inducing cell apoptosis.^[@i1552-5783-57-4-2319-b17][@i1552-5783-57-4-2319-b18]--[@i1552-5783-57-4-2319-b19]^ In the present study, we found that UV-A irradiation functionally activates p53 by phosphorylation modification at serine 15 at the amino terminus in HCEnCi with UV-A fluences of 5, 10, and 25 J/cm^2^ at 24 hours post exposure. Additionally, Western blot analysis showed that 5 J/cm^2^ UV-A promotes phospho-p53 nuclear accumulation. Concurrently, increased caspase3 activation and cytotoxicity were detected following treatment with 5, 10, and 25 J/cm^2^ UV-A. These results provided the evidence that UV-A activates p53 and apoptosis. Similarly, it has been reported that UV-A irradiation activates p53 in skin fibroblasts^[@i1552-5783-57-4-2319-b27],[@i1552-5783-57-4-2319-b28]^ and that p53 is essential for UV-A--induced apoptosis in mouse epidermal cells.^[@i1552-5783-57-4-2319-b29],[@i1552-5783-57-4-2319-b41]^ In contrast, a recent study showed that p53 is not active in response to UV-A and that UV-A facilitates apoptosis via a p53-independent pathway.^[@i1552-5783-57-4-2319-b30]^ This study reported that there was no detectable increase of sequence-specific DNA-binding activity of p53 and no induction of Ser 15 phosphorylation of p53 in 10 to 30 J/cm^2^ UV-A--treated mouse embryonic fibroblasts at 6 to 24 hours post irradiation. Another time course study on human neonatal fibroblasts displayed that phospho-53 was detected at 2 hours but not 6 to 24 hours after 10 to 30 J/cm^2^ UV-A exposure.^[@i1552-5783-57-4-2319-b31]^ Our result showing that UV-A activates p53 fits well within the range of activation profiles previously reported.^[@i1552-5783-57-4-2319-b27],[@i1552-5783-57-4-2319-b28]^ Performing p53 knockdown studies in the future will investigate whether blocking p53 action leads to decreased apoptosis indicating that UV-A induces p53-mediated apoptosis.

As transcription factors involved in oxidative stress, Nrf2 and p53 respond to ROS via different mechanisms. Nrf2-regulated antioxidant defense scavenges ROS, however, p53-induced apoptosis requires the accumulation ROS for its activation. It remains unclear whether the crosstalk between Nrf2 and p53 is synergistic, additive or suppressive. A carcinogenesis study on Nrf2 knockout and p53 heterozygotic mice showed that a Nrf2−/−::p53± mutation in mice increased the incidence of a chemical induced bladder carcinogenesis as compared with those carrying the Nrf2−/− or p53± mutation alone, indicating the cooperative and compensatory interaction between Nrf2 and p53.^[@i1552-5783-57-4-2319-b42]^ This observation, however, is challenged by more direct examination between Nrf2 and p53, which showed that overexpressed or endogenous p53 suppresses the Nrf2-dependent transactivation by interacting with and inhibiting the ARE- containing promoter of antioxidant genes, such as NQO-1, GST-α1.^[@i1552-5783-57-4-2319-b19]^ A recent study demonstrated that Nrf2-medidated antioxidant defense is regulated by p53 in two phases in a dose-dependent manner.^[@i1552-5783-57-4-2319-b43]^ Under low levels of ROS, p53 upregulates the expression of antioxidant defense genes, protecting cells from ROS-induced oxidative damage. However, at high levels of ROS, p53 expression increases and downregulates Nrf2 and its target genes.^[@i1552-5783-57-4-2319-b43]^ In our study, we found that UV-A irradiation with 5, 10, or 25 J/cm^2^ generates ROS product in a fluence-dependent manner. Nrf2-regulated antioxidants occur only with lower UV-A fluences of 2.5 and 5 J/cm^2^ at 3 to 6 hours post UV-A exposure, while increased phospho-p53 was observed at higher UV-A fluence of 5, 10, and 25 J/cm^2^ at 24 hour post treatment. It is reasonable to speculate that Nrf2-regulated antioxidants protect CEnCs from oxidative stress caused by UV-A at low levels of damage, however, high levels of oxidative damage activate p53. Additionally, the phenomenon we observed when only the lower UV-A fluences enhanced the expression of Nrf2 and its target genes is consistent with the concept of hormesis in which lower levels of a stimulator are more effective than higher ones.^[@i1552-5783-57-4-2319-b44]^

Interestingly, we observed that pretreatment of NAC prior to UV-A irradiation did not decrease Nrf2 nuclear translocation, as would be expected due to the ROS-scavenging effect of NAC in HCEnCi.^[@i1552-5783-57-4-2319-b45]^ By convention, NAC is known to scavenge ROS directly by acting as a cysteine donor and upregulating glutathione levels.^[@i1552-5783-57-4-2319-b46],[@i1552-5783-57-4-2319-b47]^ However, recent studies have shown that Nrf2 expression was directly elevated after NAC administration in phosgene-stressed rat lung tissue^[@i1552-5783-57-4-2319-b48]^ and carbon tetrachloride (CCl4)-stressed rat liver tissue.^[@i1552-5783-57-4-2319-b49]^ We speculate that NAC directly causes Nrf2 nuclear translocation in addition to scavenging ROS during UV-A irradiation of corneal endothelium.

In summary, our findings demonstrate that UV-A causes ROS-induced cytotoxicity in CEnCs. Low fluences of UV-A activate Nrf2-regulated antioxidant defense by promoting Nrf2 nuclear translocation and upregulating its target genes HO-1 and NQO-1. High fluences of UV-A irradiation lead to the activation of p53 and apoptosis. Given that previous studies have shown the critical roles of Nrf2-mediated antioxidant defense and p53 in regulating oxidative stress induced apoptosis in FECD,^[@i1552-5783-57-4-2319-b07],[@i1552-5783-57-4-2319-b08],[@i1552-5783-57-4-2319-b32]^ this study yielded not only knowledge about the cellular responses of CEnC to oxidative stress, but it may also provide an in vitro oxidative stress model for investigating CEnC degeneration, especially, in FECD pathogenesis.
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